Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 10:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–21 of 21 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Unblinded - CGM Clear all

Conditions: Type 2 Diabetes
Interventions: Dexcom continuous glucose monitor; Device
Lead sponsor: Ian J. Neeland, MD; Other
Eligibility: 18 Years to 99 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity & Overweight, Obese Adolescents, Metabolic Abnormalities
Interventions: Use of an unblinded CGM device; Device
Lead sponsor: University of Florida; Other
Eligibility: 13 Years to 17 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: PreDiabetes
Interventions: GEM, Routine Care; Behavioral · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 25 Years to 70 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Nutrition, Type 2 Diabetes, T2DM, T2DM (Type 2 Diabetes Mellitus), Diabetes Education, Diabetes Type 2, Diabetes Mellitis
Interventions: CGM-Augmented FIM, FIM only; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Hemodialysis, Diabete Mellitus, Continuous Glucose Monitoring
Interventions: Continuous glucose monitoring (CGM), Usual care (Self-monitored blood glucose); Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 99 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Orange, California

Conditions: Post-Bariatric Hypoglycemia
Interventions: Use of Continuous Glucose Monitor (CGM), Use of "Cardea Solo" monitoring; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Type 2 Diabetes
Interventions: Unblinded CGM/Nutrition Therapy, Blinded CGM/Nutrition Therapy, Unblinded CGM/No Nutrition Therapy, Blinded CGM/No Nutrition Therapy; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Polycystic Ovarian Syndrome (PCOS)
Interventions: Stelo glucose biosensor by Dexcom; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Type 2 Diabetes
Interventions: Unblinded CGM plus nutrition therapy, Nutrition therapy only; Device · Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pregnancies at Increased Risk for Excessive Gestational Weight Gain, Ecological Momentary Assessment and Intervention, Continuous Glucose Monitor
Interventions: Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancy; Behavioral
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: Continuous Glucose Monitoring, Insulin Lispro; Device · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: Escondido, California • Los Angeles, California • Ventura, California + 3 more

Conditions: Type 1 Diabetes, Prediabetic State, Dysglycemia, Autoimmune Diabetes
Interventions: Early CGM-guided education and initiation of insulin therapy., Usual care: glucometer surveillance and basic education.; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 2 Years to 20 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Diabetes Mellitus
Interventions: Continuous Glucose Monitoring, Care Coordination; Device · Other
Lead sponsor: Mark O'Connor; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Infant, Very Low Birth Weight, Neonatal Hypoglycemia
Interventions: Unblinded - CGM, Blinded - CGM; Device
Lead sponsor: University Hospital Padova; Other
Eligibility: 2 Hours to 2 Days
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus
Interventions: Not listed
Lead sponsor: DexCom, Inc.; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Pregnancy, High Risk, Type 1 Diabetes, Type 2 Diabetes
Interventions: Insulin, DEXCOM Continuous Glucose Monitor; Drug · Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: End Stage Kidney Disease (ESKD), Hyperglycaemia, Diabetes
Interventions: Continuous Glucose Monitoring (CGM); Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Virtual Clinic; Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: type1diabetes
Interventions: Libre 2, Device for SMBG and Libre Pro; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 4 Years to 26 Years
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Type 2 Diabetes
Interventions: CGM Group, SMBG Group; Device
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Gestational Diabetes Mellitus in Pregnancy
Interventions: Diabetes Treatment, Usual Care Group; Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 18 Years and older · Female only
Enrollment: 6,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: Birmingham, Alabama • Miami, Florida • Decatur, Georgia + 5 more

Search by objective public record fields.

Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes

A Study Comparing Continuous Glucose Monitoring Augmented Nutritional Counseling and Standard of Care Treatment Strategies in a Three-Month Nutrition Intervention

CGM Plus GEM in Prediabetes

Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine

Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial

Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia

Individualized Diabetes Education Assisted by CGM (IDEA-CGM)

Continuous Glucose Monitoring in Polycystic Ovarian Syndrome

Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus

Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study

Assessment of Mealtime Bolus Insulin Behavior

Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D

Glycemic Optimization On Discharge From the Emergency Room

Continuous Glucose Monitoring and Preterm Infants

Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus

Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)

Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring

Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose Monitoring

Diabetes in African Youth

Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes

CGM for the Early Detection and Management of Hyperglycemia in Pregnancy